Aiolum Browse stories
All stories
AI data analyst for biology labs · USA

NovaFlow: Product, team and how it was built

Small teamFundedB2BBiotechnology

NovaFlow (AI data analyst for biology labs, USA): Self-serve paid plans on sale, November 2026. Evidence grade E: no revenue figure was checked. Team: 4 people, Y Combinator Summer 2025. Launched July 2025; still running.Added

Outcome
Self-serve paid plans on sale, November 2026
Evidence
E no revenue figure was checked
Launch
July 2025
Status
Still running
Team
4 people, Y Combinator Summer 2025
Outside funding
Backed by Y Combinator, BioRender and FCVC; no amount stated
Main channel
Not stated
No revenue figure

What is not verified

No revenue figure was found. No source states that a customer has paid for a plan. Looked for: a payment-processor profile, a founder interview, press, a case study and the terms of service. A reader could ask the company for paid users. This story is grade E: the business is real and its product, price and customers are described from public pages, but no revenue figure was checked. Aiolum shows it as an idea worth studying, not as proof that it makes money.

NovaFlow is an AI data analyst for biology labs. Bioinformatics is the use of code and statistics to analyse biological data such as gene activity in cells. The user uploads data and describes the experiment. NovaFlow writes and runs the code, and returns plots, a report and a notebook.

The Y Combinator page lists the company as founded in 2025, in the Summer 2025 batch, with a team of 4. Amulya Balakrishnan is listed as Founder and CEO. The launch post says the other founder was a computational biologist who saw labs spend heavily on analysis. The product first appeared on another domain, as a waitlist page in July 2025.

No revenue figure was found, so this is a grade E story. The company's pricing page lists a free plan, a Pro plan at US$20 a month and a Max 20x plan at US$200 a month. It was read on 12 November 2026. No source says that a customer has paid.

NovaFlow: Self-serve paid plans on sale, November 2026. AI data analyst for biology labs, USA, team of 2 to 10, evidence grade E.
The story in one card. Share it with the address of this page.
01

Why did NovaFlow work?

Four causes, in the order they mattered. Each one is a reusable lesson.

01

A computational biologist founded it after seeing labs wait

The launch post says one founder worked as a computational biologist and saw colleagues wait for analysis. That is the company's own account, and no source checks it.

02

The product runs the analysis code instead of the analyst

The company describes a workflow with several steps. It checks the data, reviews literature and asks the user to approve a plan. It then runs R and Python and returns a cited report. Every plan includes all steps.

03

Plans differ only in how much usage they include

Free, Pro and Max 20x run the same workflow. A user who reaches the limit pauses until the next billing month or upgrades. This is a usage-based price, not a feature-based one.

How it was built

These details come from the company's own pages. They are grade C. [2, 4, 8, 1]

  • A web app at app.novaflow.ai with a sign-in page. Its public pages are built with Next.js, which the page code shows.
  • The product writes and runs Python and R code. It exports notebooks, according to the pricing page and the launch post.
  • The services page also lists a command-line tool, analysis portals and a standalone engine for a lab's own infrastructure.
  • Demos are booked through a Calendly link. The blog is on Substack.

Tools named in the sources

Each one opens its page in the Tools tab, with every story that uses it.

02

Who tried this before NovaFlow, and why did they fail?

Three companies in our database of failed startups tried to sell data analysis or computational biology as a product. The values below are from that database, read on 12 November 2026, and are not independently verified.

Died 2018 to 2025Burned US$40M

Spotlight Bio

The promise

A platform that uses genomics and computation to find drug targets.

Why it died

The record says predictions without wet-lab validation proved hard to turn into a business.

Business model
Died 2012 to 2015Burned US$120K

DataNitro

The promise

Run Python scripts inside Excel for data analysis.

Why it died

The record says the design of Excel limited the product. It adds that Python built into Excel by Microsoft made the product obsolete.

Competition
Died 2017 to 2020Burned US$15M

Cambridge Cancer Genomics

The promise

Genomic sequencing and machine learning to tailor cancer therapies.

Why it died

The record names slow adoption in health care and regulatory challenges.

Regulation

The failed startups come from our database of 1,749 dead startups, retold here in our own words. Its entries are AI-assisted summaries of public sources, so these cards carry no evidence grade.

What changed

Each predecessor sold either a hard science platform or a tool inside someone else's product. NovaFlow sells a general analysis workflow to labs that already hold the data. The sources do not show whether labs pay for it.

The difference is the way the work is done. A language model writes the analysis code, so the lab does not wait for an analyst. The company claims this saves time, and no source tests the claim.

03

Can one person copy NovaFlow now?

The idea, yes. The business is not proven.

A narrow analysis task that experts do slowly can be turned into a usage-priced software plan. No source shows that NovaFlow has paying customers yet. Copy the structure, and check demand first.

Where it is still open: Other fields where specialists run code for researchers: chemistry, imaging, clinical data and materials.

  1. 1Pick one expert task with a long wait, such as the analysis of lab data.
  2. 2Show the full workflow on the free plan, and sell more usage.
  3. 3Publish prices and a way to upgrade, so a buyer needs no call.
04

How much revenue does NovaFlow make?

Each row shows the evidence grade and the source numbers from the list at the end of this page. The grades are explained in How Aiolum verifies.

A company with paid plans on sale and no revenue figure. Team, batch and start year come from the Y Combinator page and from a July 2025 copy of an older product page
FactValueGradeHow we knowSources
Company start2025CThe Y Combinator page says "Founded: 2025". A copy of the older product page from 24 July 2025 shows the same product as a waitlist.[1, 5]
Y Combinator batchSummer 2025CY Combinator company page, read 12 November 2026. Status on that page: Active.[1]
Team size4 peopleCY Combinator page, "Team Size: 4". The page lists one active founder by name.[1]
Founder named by a sourceAmulya Balakrishnan, Founder/CEOCY Combinator page. The launch post on that page names a second founder by first name only.[1]
Plans on sale, November 2026Free, Pro, Max 20x and EnterpriseCCompany pricing page. The Pro and Max buttons lead to the sign-in page of the app. The FAQ says a plan is changed in Settings in the app.[2]
Price of Pro and Max 20xUS$20 and US$200 a monthCThe company's pricing page states these prices. Max 20x includes 20 times the usage of Pro.[2]
Price on the July 2025 waitlist pageIndividual plan, US$75 a monthCThe company's page of 24 July 2025, read in a Wayback copy. Its button said "Join waitlist".[5]
Users named by the companyresearchers at UCSF, Mount Sinai, UC Berkeley and HarvardCThe Y Combinator launch page says researchers there "are already using" the product. It does not say they pay.[1]
Counters on the home page12+ hours saved a week, 40% faster, 2.4M+ data pointsCCompany home page, no source or date given for the counters.[3]
Outside backingY Combinator, BioRender and FCVCCThe home page says "Backed by Y Combinator BioRender FCVC + more". No amount is stated.[3]

How to read this table. Grade C is a statement by the company or by its Y Combinator profile. No value is verified by a payment processor, a buyer or the press.

NovaFlow plans as the company's pricing page showed them on 12 November 2026 (grade C)
PlanPer month, billed yearly (US$)Per month, billed monthly (US$)Limit
Free00standard monthly usage
Pro20more usage than Free
Max 20x20020 times the usage of Pro
Enterprisecustomcustom limits, security review, dedicated contact

The page states prices per month and no yearly discount. Every plan runs the same workflow; plans differ in monthly usage. Enterprise adds custom limits and a security review.

05

When did NovaFlow launch, and how did it grow?

From a waitlist page in July 2025 to paid plans on a new domain by November 2026. Each entry carries its grade.

  1. 2025CCompany founded, according to the Y Combinator page. It joins the Summer 2025 batch. [1]
  2. 24 July 2025CThe older product page shows an Individual plan at US$75 a month with a waitlist button, and Labs and Enterprise plans on request. [5]
  3. 18 November and 8 December 2025CCopies of the novaflow.ai domain show another company's documentation site, not this product. [6]
  4. 4 June 2026CThe newest of three blog posts on the company blog is dated this day. [8]
  5. 12 November 2026Cnovaflow.ai shows the product, a pricing page with Pro at US$20 a month and Max 20x at US$200 a month, and the "© 2026 NovaFlow" footer. [2, 3]

What could go wrong for NovaFlow?

The risks are the mirror image of the causes above.

What is not verified

No revenue figure was found. No source states that a customer has paid for a plan. Looked for: a payment-processor profile, a founder interview, press, a case study and the terms of service. A reader could ask the company for paid users.

Logo wall and counters have no source

The home page shows 11 logos under "Trusted by Researchers at leading institutions": nine universities and medical centres and two companies. It names no customer in text and gives no date. The counters of 12+ hours, 40% and 2.4M+ also have no stated basis. The waitlist page of July 2025 showed three testimonials from named researchers. The current site shows none of them.

Software and services are mixed

The home page says the product combines software with "an expert scientific team". The services page offers consultation, custom pipeline work and a standalone engine. The pricing page sells only software plans.

The domain had earlier owners

Before this product, novaflow.ai showed a website template for image generation in 2024. In November and December 2025 it showed the documentation of another company, Nova Cognitive Systems LLC. The product used an older domain in July 2025.

Sources

The grade next to each source is the best grade that the source can support. "Read in full" means that the text of the page was downloaded and the numbers were checked in it.

  1. C Y Combinator company page: Novaflow, The AI data analyst for biology labs
    Read in full on 12 November 2026. Source for founding year, batch, team size, the named founder and the launch post.
  2. C NovaFlow pricing page
    Read in full on 12 November 2026. Source for the plans, the prices, the usage rules and the upgrade path.
  3. C NovaFlow home page
    Read in full on 12 November 2026. Source for the product, the counters, the logo wall and the backers.
  4. C NovaFlow services page
    Read in full on 12 November 2026. Source for the services, the command-line tool and the standalone engine.
  5. C Wayback copy of novaflowapp.com, 24 July 2025: Novaflow - AI Bioinformatics Analysis
    Read the text of the page. Source for the waitlist, the Individual plan and the start in 2025.
  6. C Wayback copies of novaflow.ai, 18 November and 8 December 2025 (Nova Cognitive Systems LLC)
    Read both copies in full. Source for the earlier owner of the domain.
  7. C Wayback copies of novaflow.ai, 30 August and 24 December 2024
    Read the start of both copies. Source for the website template shown in 2024.
  8. C NovaFlow blog index
    Read in full on 12 November 2026. Source for the three posts, the Substack link and the post dates.
  9. C Database of failed startups, local export
    Record pages read on the website on 12 November 2026. AI-written summaries, not independently verified. Source for the predecessors.

Run this company? Send corrections or a verified figure to aiolum@livyden.com

Back to all stories